Fox Chase Cancer Center News

Genome Profiling, Fox Chase Cancer Center to Collaborate on Immune System Blood Test to Predict Checkpoint Inhibitor Response in Non-Small Cell Lung Cancer

PHILADELPHIA (July 13, 2020) – Genome Profiling and Fox Chase Cancer Center will collaborate to identify a novel immune system epigenetic biomarker, dubbed EpiMarker, which if successful, will be used to help predict which lung cancer patients are likely to respond to a checkpoint inhibitor therapy known as anti-PD1 antibody. These agents are a potentially valuable tool for lung cancer treatment, but it remains very difficult for doctors to predict which patients are most likely to benefit from them.

VIEW STORY

Study by Fox Chase Researchers Indicates Gene Mutations From UV Exposure May Play Role in Melanoma Malignancy

PHILADELPHIA (June 29, 2020)—Researchers at Fox Chase Cancer Center recently conducted a study analyzing the impact of sun exposure and tanning patterns on gene mutations in patients with advanced melanoma. Those who experienced blistering sunburn had a higher number of gene mutations in their tumors compared to those who did not experience blistering sunburn.

VIEW STORY

Fox Chase Cancer Center Welcomes Weier Li

PHILADELPHIA (June 24, 2020) – Fox Chase Cancer Center announces the hiring of Weier Li, MD, who will join the Department of Diagnostic Imaging as a full time body imager. Li will join Fox Chase as an assistant professor.

VIEW STORY

Fox Chase Researchers Receive Grant to Study Approaches for Empowering Asian American Women in Cervical Cancer Screening

PHILADELPHIA (June 22, 2020)—Carolyn Y. Fang, PhD, was recently awarded a grant for the first large-scale study evaluating a method that allows Asian American women to collect their own samples, which can then be tested for the presence of the human papilloma virus (HPV). Fang will be conducting the research with Grace X. Ma, PhD, multiple principal investigator for the study.

VIEW STORY